Aldeyra Therapeutics, Inc. - Common Stock — Quarterly Balance Sheet (NASDAQ:ALDX) | MetaTrader

Open full chart

News

Here's Why You Should Add ARQT Stock to Your Portfolio Now

Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection

Aldeyra Therapeutics: What Comes Next After Reproxalap's Third CRL (NASDAQ:ALDX)

Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims - TipRanks.com

AbbVie: Buy Or Sell Ahead Of Q1 Earnings? It's A Buy, But With Caveats (Upgrade) (ABBV)

ALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDA

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.10%

RBC reiterates Bausch & Lomb stock rating on DED rival delay

FDA rejects Aldeyra’s dry eye disease drug application

Is Aldeyra Therapeutics (ALDX) Outperforming Other Medical Stocks This Year?

Does Aldeyra Therapeutics (ALDX) Have the Potential to Rally 79.28% as Wall Street Analysts Expect?

Top Healthcare Stocks for This Year According to BTIG